Why the study?
Does the fixed combination of nebivolol and hydrochlorothiazide improve blood pressure without adverse metabolic effects in patients with hypertension?
Does the fixed combination of nebivolol and hydrochlorothiazide improve blood pressure without adverse metabolic effects in patients with hypertension?
The fixed-dose combination of nebivolol and hydrochlorothiazide is an effective and metabolically safe antihypertensive therapy.
Authors
No takes yet. Share an insight, caveat, or question.
May support nebivolol-hydrochlorothiazide for BP lowering; leaves open outcome benefits in hypertension.
Barna et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: